Chronic hepatitis B patients with high-normal serum ALT (levels of 0.5-1؋ upper limit of normal) are still at risk of liver disease progression. We thus investigated the correlation between serum ALT level and hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum ALT level (PNALT). Baseline clinical and virological features of 414 HBeAg-negative carriers, including 176 (42.5%) with low-normal ALT (levels of less than 0.5؋ upper limit of normal) and 238 (57.5%) with high-normal ALT, were compared. Compared with HBV carriers with low-normal ALT, those with high-normal ALT were older (41 vs. 37 years, P < 0.001) and had a greater frequency of serum HBV DNA level >10 4 copies/ml (63.4% vs. 47.5%, P < 0.001) as well as a higher prevalence of basal core promoter T1762/A1764 mutant (36.5% vs. 24.2%, P ؍ 0.01). Multivariate analysis showed that factors associated with a high-normal serum ALT level included male sex [odds ratio ( T he natural history of chronic HBV infection could be generally divided into three chronological stages. 1 During the immune tolerance stage, serum HBV DNA levels are high and hepatitis B e antigen (HBeAg) is present. In the immune clearance stage, most carriers eventually seroconvert from HBeAg to anti-HBe. After HBeAg seroconversion, patients were in the integration or residual stage, serum level of HBV DNA decreased, and ALT became normal. Accordingly, HBeAgnegative carriers were usually considered to have lowreplicative HBV infection, and normal or nearly normal serum ALT levels. However, progressive liver disease still develops in HBeAg-negative carriers because of bouts of hepatitis flare. Thus, the clinical spectrum of HBeAgnegative chronic HBV infection may range from inactive carrier to aggressive chronic hepatitis with or without cirrhosis. 2 The differential diagnosis of HBeAg-negative chronic hepatitis from an inactive carrier mainly depends on sequential determinations of serum ALT. 3 However, slightly increased serum ALT level, although within the normal range, has been reported to be significantly associated with risk of liver-related mortality in the general population. 4 Furthermore, recent large-scale cohort studies showed that chronic hepatitis B patients with a normal serum ALT level, irrespective of HBeAg status, were also at a risk for the development of cirrhosis and HCC. 5,6 Therefore, chronic hepatitis B patients with high-normal serum ALT levels (0.5-1 ϫ upper limit of normal) may be From the